Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences — Research
Fellow / Postdoctoral Researcher (2022–Present)
- Led AI-driven health risk modeling, resulting in a patented method for personalized health management.
- Conducted deep-dive research into cardiovascular and metabolic diseases and provided strategic recommendations on tech development and health management solutions.
- Designed feasibility assessments for digital health and medical device projects;
collaborated with clinicians, engineers, and policymakers.
- Evaluated payer-side value frameworks and provided insights for commercialization and regulatory alignment.
- Impact: Delivered insights influencing product development decisions, optimizing risk assessment pathways and evidence generation strategies.
Qianhai Reinsurance Co., Ltd.
—
Healthcare Research (2022–2024)
- Assessed cost-effectiveness and real-world value of emerging drugs and medical devices to support payer and pricing decisions.
- Contributed to health insurance product strategy, integrating clinical evidence and actuarial risk models.
- Conducted technology landscape research and competitive analysis for innovative health solutions
Impact: Improved underwriting logic and product design for chronic disease management and health insurance products.
INSERM & University of Lyon
—
PhD Researcher (2016–2020)
- Led multiple large-scale RWE projects using French national health insurance (SNDS) database.
- Designed and executed clinical trials evaluating drug/device outcomes.
- Translated complex clinical data into clear insights for academic and industry partners.
- Impact: Published influential research and advised teams on clinical trial design and evidence strategies.
University Hospital of Lyon — Specialist Resident Physician (2014–2016)
- Managed patient care involving stroke, cardiovascular disease, and complex rehabilitation.
- Collaborated with multidisciplinary clinical teams to optimize treatment pathways.
- Impact: Developed deep understanding of disease mechanisms, patient journeys, and real-world treatment decision-making.
